Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Rheumatology|April 22, 2020
Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritisC Vinci, M Infantino, S Raturi, et al.
European Urology Open Science|August 2, 2021
Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal MetastasisChara Ntala, Mark Salji, Jonathan Salmond, et al.
Arthritis Research & Therapy|August 3, 2019
Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritisC G Fenton, J M Webster, C S Martin, et al.
Oncogene|November 20, 2019
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
Oncogene|December 21, 2019
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Annals of the Rheumatic Diseases|October 18, 2025
Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid responseCecilia Ansalone, Samuel McAllister, Ethan S Pickerill, et al.
Therapeutic Advances in Musculoskeletal Disease|September 11, 2023
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritisOliver FitzGerald, Frank Behrens, Anne Barton, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
British Journal of Haematology|November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipientsHayley Colton, Natalie Barratt, Nigel Temperton, et al.
Pageof 11